These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 20205324

  • 1. [Correction of protein-energy metabolism in hepatorenal failure in surgical patients].
    Dibirov MD, Kostiuchenko MV.
    Eksp Klin Gastroenterol; 2009; (6):77-81. PubMed ID: 20205324
    [Abstract] [Full Text] [Related]

  • 2. [Correction of protein-energy metabolism in elderly patients with acute intestinal obstruction and hepatorenal dysfunction].
    Kostiuchenko MV.
    Eksp Klin Gastroenterol; 2011; (3):88-92. PubMed ID: 21698813
    [Abstract] [Full Text] [Related]

  • 3. [Hepato-renal syndrome and problem of protein-energy metabolism correction during urgent surgery of the abdominal organs].
    Dibirov MD, Briskin BS, Kostiuchenko MV, Dobriakova EA, Mkhitarova LA.
    Eksp Klin Gastroenterol; 2009; (2):83-7. PubMed ID: 19552025
    [Abstract] [Full Text] [Related]

  • 4. [The magneto-laser effect on liver functions in the complex treatment of hepatorenal failure].
    Shimanko II, Limarev VM.
    Anesteziol Reanimatol; 1993; (5):49-51. PubMed ID: 8116903
    [Abstract] [Full Text] [Related]

  • 5. [Characteristics of protein metabolism changes in oncology patients with surgical and combined treatment].
    Tsvetkov DS, Kulabukhov VV, Nuzhdin IL, Chizhov AG.
    Anesteziol Reanimatol; 2004; (2):54-7. PubMed ID: 15206281
    [Abstract] [Full Text] [Related]

  • 6. [Acute postoperative hepatorenal failure in surgical patients].
    Uzhva VP, Bondarenko IN.
    Vestn Khir Im I I Grek; 1990 May; 144(5):120-2. PubMed ID: 2175970
    [No Abstract] [Full Text] [Related]

  • 7. [Hepatorenal syndrome].
    Radziszewski A, Sułowicz W.
    Przegl Lek; 2006 May; 63(7):573-8. PubMed ID: 17203812
    [Abstract] [Full Text] [Related]

  • 8. [Changes in the catabolic phase of the postoperative period in the case of complications].
    Bagényi J, Horváth M, Imre J, Gaál T, Petri G.
    Nahrung; 1972 May; 16(2):107-18. PubMed ID: 4625536
    [No Abstract] [Full Text] [Related]

  • 9. Hepatorenal syndrome.
    Cárdenas A, Gines P.
    Clin Liver Dis; 2006 May; 10(2):371-85, ix-x. PubMed ID: 16971267
    [Abstract] [Full Text] [Related]

  • 10. [Therapy of hepatorenal syndrome].
    Walter E.
    Praxis (Bern 1994); 1997 Jan 21; 86(4):102-3. PubMed ID: 9064719
    [Abstract] [Full Text] [Related]

  • 11. [Correction of cardiovascular function in acute hepatorenal insufficiency].
    Musselius SG, Aleksandrova IV, Strokov VA.
    Sov Med; 1987 Jan 21; (11):93-6. PubMed ID: 3445157
    [No Abstract] [Full Text] [Related]

  • 12. Impact of pretransplant renal function on survival after liver transplantation.
    Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS.
    Transplantation; 1995 Feb 15; 59(3):361-5. PubMed ID: 7871566
    [Abstract] [Full Text] [Related]

  • 13. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.
    Hepatogastroenterology; 2003 Feb 15; 50(54):1753-5. PubMed ID: 14696397
    [Abstract] [Full Text] [Related]

  • 14. Hepatorenal syndrome: emerging perspectives.
    Epstein M.
    Semin Nephrol; 1997 Nov 15; 17(6):563-75. PubMed ID: 9353866
    [Abstract] [Full Text] [Related]

  • 15. Postoperative ICU management in liver transplant patients.
    Saner F, Kavuk I, Lang H, Frühauf NR, Paul A, Stavrou G, Malagó M, Broelsch CE.
    Eur J Med Res; 2003 Nov 12; 8(11):511-6. PubMed ID: 14644707
    [Abstract] [Full Text] [Related]

  • 16. Evolution of hepatorenal syndrome after orthotopic liver transplantation: comparative analysis with patients who developed acute renal failure in the early postoperative period of liver transplantation.
    López Lago AM, Fernández Villanueva J, García Acuña JM, Paz ES, Vizoso EF, Pérez EV.
    Transplant Proc; 2007 Sep 12; 39(7):2318-9. PubMed ID: 17889176
    [Abstract] [Full Text] [Related]

  • 17. [Efficiency of dialysis with albumin in the treatment of patients with advanced hepatic insufficiency: initial experience with the MARS system in Spain].
    Avilés J, Macía M, Morales S, Pérez F, Moreno A, Navarro J, Navazo L, García J.
    Nefrologia; 2001 Sep 12; 21(4):376-85. PubMed ID: 11816514
    [Abstract] [Full Text] [Related]

  • 18. [Role of platelet activating factor in hepatorenal syndrome].
    Xie DS, Xie YT.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun 12; 30(3):349-51. PubMed ID: 16045031
    [Abstract] [Full Text] [Related]

  • 19. [Hepatorenal syndrome: pathogenesis and treatment].
    Ashkenazi E, Ilan Y, Shoval D.
    Harefuah; 2007 Jun 12; 146(6):475-9, 499. PubMed ID: 17760404
    [Abstract] [Full Text] [Related]

  • 20. Management of hepatorenal syndrome.
    McCormick PA, Donnelly C.
    Pharmacol Ther; 2008 Jul 12; 119(1):1-6. PubMed ID: 18539334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.